日常实践中症状性颈动脉狭窄早期颈动脉支架置入术的安全性
全队列卒中/死亡率为2.2%(27例),早期与延迟期无显著差异,结论认为早期支架置入术可能安全,但需进一步研究验证更早期急性期实施的安全性。
要点
- 全队列30天卒中/死亡率为2.2%(27例),早期组2.7%(8例) vs 延迟组2%(19例),p=.47。
- 早期与延迟组在TIA、小卒中、大卒中及死亡发生率上均无显著差异。
- 作者认为缺血性卒中后早期行颈动脉支架置入术可能安全,但需进一步研究验证更早期急性期实施的安全性。
核心结论
- 作者认为,缺血性卒中后早期行颈动脉支架置入术可能安全,临床并发症发生率低。
- 需要进一步研究以验证在缺血性卒中更早期急性阶段实施颈动脉支架置入术的安全性。
研究设计与样本
- 共识别1227例症状性颈动脉狭窄行颈动脉支架置入术的患者,早期(卒中发作后≤14天)291例,延迟期(15-180天)936例。
- 排除因急性缺血性卒中接受颈动脉支架置入术和/或机械取栓治疗的患者。
- 评估30天发病率(任何卒中,不含TIA/一过性黑矇)及手术死亡率。
主要发现
- 全队列30天发病率(任何卒中)和死亡率为2.2%(n=27):早期组2.7%(n=8) vs 延迟组2%(n=19),p=.47。
- TIA:早期组5.2%(n=15) vs 延迟组3.9%(n=36),p=.33,无显著差异。
- 小卒中:早期组1.4%(n=4) vs 延迟组0.5%(n=5),p=.14,无显著差异。
- 大卒中:早期组0.7%(n=2) vs 延迟组0.6%(n=6),p=.59,无显著差异。
- 死亡:早期组0.7%(n=2) vs 延迟组0.9%(n=8),p=.56,无显著差异。
关键数值与推荐
- 2006年美国心脏协会(AHA)推荐:对于症状性颈动脉狭窄,理想情况下应在缺血事件后14天内行颈动脉内膜切除术(CEA),或选择颈动脉血管成形术和支架置入术(CAS)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以验证在缺血性卒中更早期急性阶段实施颈动脉支架置入术的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/BACKGROUND: In 2006, the American Heart Association recommended that for preference carotid endarterectomy (CEA) or, alternatively, carotid angioplasty and stenting (CAS) for symptomatic carotid artery stenosis should ideally occur within 14 days of an ischaemic event. The aim was to determine the safety of CAS according to those recommendations in daily practice. METHODS: A retrospective analysis was performed of all consecutive patients (2000-16), with ipsilateral carotid symptoms who underwent CAS for extracranial carotid stenosis ≥70%, who were previously included in a prospective database. Thirty day morbidity was assessed (any stroke without transient ischaemic attack [TIA]/amaurosis fugax), along with mortality of the procedure in the early (≤14 days after stroke onset) and delayed phases (15-180 days after stroke onset). Patients who received CAS and/or mechanical thrombectomy for acute ischaemic stroke treatment were not included. RESULTS: In total, 1227 patients with symptomatic carotid stenosis who underwent CAS were identified. Early and delayed CAS was performed in 291 and 936 patients, respectively. Morbidity (any stroke) and mortality was 2.2% (n = 27) in the whole cohort (n = 8 [2.7%] in early vs. n = 19 [2%] in delayed CAS; p = .47). There were no differences in morbidity between early and delayed CAS regarding TIA (n = 15 vs. 36 [5.2% vs. 3.9%]; p = .33), minor stroke (n = 4 vs. 5 [1.4% vs. 0.5%]; p = .14), or major stroke (n = 2 vs. 6 [0.7% vs. 0.6%]; p = .59). Two patients (0.7%) died after early CAS and eight (0.9%) after delayed CAS (p = .56). CONCLUSION: CAS may be safely performed in the early phase after an ischaemic stroke with low clinical complication rates. Further studies are needed to validate CAS safety conducted even earlier in the acute phase of ischaemic stroke.
引用
- Alcalde-López J, Zapata-Arriaza E, Cayuela A, et al. Safety of Early Carotid Artery Stenting for Symptomatic Stenosis in Daily Practice. Eur J Vasc Endovasc Surg. 2018. PMID: 30177414. doi:10.1016/j.ejvs.2018.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。